Oncological drug discovery: AI meets structure-based computational research.

Gorostiola González, Marina; Janssen, Antonius P A; IJzerman, Adriaan P; Heitman, Laura H; van Westen, Gerard J P

Gorostiola González, Marina; Janssen, Antonius P A; IJzerman, Adriaan P; Heitman, Laura H; van Westen, Gerard J P.

Afiliación

Gorostiola González M; Division of Drug Discovery and Safety, Leiden Academic Centre for Drug Research, Leiden University, the Netherlands; Oncode Institute, Utrecht, the Netherlands.
Janssen APA; Oncode Institute, Utrecht, the Netherlands; Molecular Physiology, Leiden Institute of Chemistry, Leiden University, the Netherlands.
IJzerman AP; Division of Drug Discovery and Safety, Leiden Academic Centre for Drug Research, Leiden University, the Netherlands.
Heitman LH; Division of Drug Discovery and Safety, Leiden Academic Centre for Drug Research, Leiden University, the Netherlands; Oncode Institute, Utrecht, the Netherlands.
van Westen GJP; Division of Drug Discovery and Safety, Leiden Academic Centre for Drug Research, Leiden University, the Netherlands. Electronic address: gerard@lacdr.leidenuniv.nl.

Drug Discov Today ; 27(6): 1661-1670, 2022 06.

Article en En | MEDLINE | ID: mdl-35301149

Asunto(s)

Inteligencia Artificial; Descubrimiento de Drogas; Descubrimiento de Drogas/métodos; Aprendizaje Automático

Palabras clave

Artificial intelligence; Cancer; Hallmarks of cancer; Machine learning; Structure-based drug design

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Inteligencia Artificial / Descubrimiento de Drogas Idioma: En Revista: Drug Discov Today Asunto de la revista: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Año: 2022 Tipo del documento: Article País de afiliación: Países Bajos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google